Atlas Trials

Zhigang Li

3 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Zhigang Li

RecordFirmDate
SHR-1701 in Combination With Irinotecan Liposome (II) for Second-line Treatment of ESCC After Immunotherapy (NCT07524374)Zhigang Li2026-03-15
Active Surveillance After Neoadjuvant Adebrelimab Combined With Chemoradiotherapy for Resectable ESCC (NCT06861894)Zhigang Li2025-07-01
Camrelizumab Plus Neoadjuvant Chemotherapy or Chemoradiotherapy Versus Chemoradiotherapy in Resectable ESCC. (NCT05043688)Zhigang Li2021-09-01

Track Zhigang Li automatically

Every clearance here is in the API, with alerts when new ones post.